![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Richardson Paul G
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.5, Iss.6, 2004-06, pp. : 1321-1331
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bortezomib: A Review of its Use in Patients with Multiple Myeloma
By Curran Monique P. McKeage Kate
Drugs, Vol. 69, Iss. 7, 2009-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bortezomib for multiple myeloma
By Popat Rakesh Joel Simon Oakervee Heather Cavenagh Jamie
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 10, 2006-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
An expanding VISTA for bortezomib in multiple myeloma
Inpharma, Vol. 1, Iss. 1645, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Opoku-Ansah John Ibarra-Rivera Tannya R. Pirrung Michael C. Bachmann André S.
Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 50, Iss. 1, 2012-01 ,pp. :